Streetbeat News

Regulatory

IOVA

Iovance Biotherapeutics has announced regulatory and clinical updates for TIL therapy in advanced non-small cell lung cancer, which has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

July 10, 2023 | 2:22 pm

KBE

KRE

SPY

XLF

The Federal Reserve's Barr has proposed extending enhanced capital standards to banks with $100B in assets, a significant decrease from the previous $700B threshold, according to the Wall Street Journal.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 2:18 pm

SPY

FundStrat's Tom Lee, a bullish analyst, predicts a 1% rally in the S&P 500 Index this week, expecting the consumer price inflation (CPI) report to show a lower than expected inflation rate of 0.2% or less. This would be the lowest since August 2021, indicating that the Federal Reserve is achieving its target inflation levels. Lee also sees China's deflationary trend positively impacting the U.S. The SPDR S&P 500 ETF Trust (NYSE:SPY) slightly declined by 0.03% to $438.46.

Portfolio Pulse from Shanthi Rexaline

July 10, 2023 | 2:16 pm

KBE

KRE

SPY

XLF

The Federal Reserve's Barr announced that changes to regulation and supervision are expected in the coming months. This includes higher capital requirements for the biggest banks, with new rules necessitating an extra $2 of capital for every $100 of risk-weighted assets.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 2:16 pm

SPY

The USA CB Employment Trends Index for June came in at 114.31, lower than the estimated 116.26 and the prior figure of 115.53.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 2:01 pm

KBE

KRE

SPY

XLF

Federal Reserve Vice Chair Michael Barr is discussing bank capital in a live session. The ETFs KBE, KRE, SPY, and XLF may be mentioned during the discussion.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:57 pm

NVO

The European Medicines Agency is investigating Novo Nordisk's weight-loss medications, including Saxenda, Ozempic, and Wegovy, due to reports of suicidal risks. The investigation was initiated after the Icelandic Medicines Agency reported two cases of suicidal thoughts linked to these drugs. Despite the investigation, Novo Nordisk's shares are slightly up.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 1:54 pm

IXHL

Incannex Healthcare Limited (NASDAQ:IXHL) plans to redomicile from Australia to the United States and list all its shares on Nasdaq. The company has already registered its ordinary shares with the US Securities and Exchange Commission and has been trading in the US since February 2022. The redomiciliation is subject to approval from Incannex's shareholders and optionholders, as well as regulatory and court approvals. The company believes that becoming a US company and trading only on Nasdaq will provide many benefits, including greater access to capital markets and a broader investor base.

Portfolio Pulse from Vuk Zdinjak

July 10, 2023 | 1:49 pm

IMMX

Nexcella, a subsidiary of Immix Biopharma, has completed its initial CAR-T NXC-201 engineering batch at its U.S. manufacturing site. This is a significant step towards expanding the Phase 1b/2a NEXICART clinical trial to the U.S. NXC-201 is the first CAR-T being developed in AL Amyloidosis and has shown promising results in relapsed/refractory AL amyloidosis and multiple myeloma patients. The therapy could potentially reduce hospitalization costs by up to 80%.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:47 pm

CRBU

PFE

Pfizer Inc. has increased its stake in Caribou Biosciences, Inc. to 7.1%, according to a 13G filing with the SEC.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:46 pm